These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 29588316)
21. Impaired Autophagy in CD11b Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723 [TBL] [Abstract][Full Text] [Related]
22. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression. Sharma M; Schlegel MP; Afonso MS; Brown EJ; Rahman K; Weinstock A; Sansbury BE; Corr EM; van Solingen C; Koelwyn GJ; Shanley LC; Beckett L; Peled D; Lafaille JJ; Spite M; Loke P; Fisher EA; Moore KJ Circ Res; 2020 Jul; 127(3):335-353. PubMed ID: 32336197 [TBL] [Abstract][Full Text] [Related]
23. Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. Wigren M; Kolbus D; Dunér P; Ljungcrantz I; Söderberg I; Björkbacka H; Fredrikson GN; Nilsson J J Intern Med; 2011 May; 269(5):546-56. PubMed ID: 21114693 [TBL] [Abstract][Full Text] [Related]
24. Tc17 CD8+ T cells accumulate in murine atherosclerotic lesions, but do not contribute to early atherosclerosis development. van Duijn J; de Jong MJM; Benne N; Leboux RJT; van Ooijen ME; Kruit N; Foks AC; Jiskoot W; Bot I; Kuiper J; Slütter B Cardiovasc Res; 2021 Dec; 117(14):2755-2766. PubMed ID: 33063097 [TBL] [Abstract][Full Text] [Related]
25. The Role of T Cells Reactive to the Cathelicidin Antimicrobial Peptide LL-37 in Acute Coronary Syndrome and Plaque Calcification. Chernomordik F; Cercek B; Lio WM; Mihailovic PM; Yano J; Herscovici R; Zhao X; Zhou J; Chyu KY; Shah PK; Dimayuga PC Front Immunol; 2020; 11():575577. PubMed ID: 33123157 [TBL] [Abstract][Full Text] [Related]
26. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis. Gisterå A; Hermansson A; Strodthoff D; Klement ML; Hedin U; Fredrikson GN; Nilsson J; Hansson GK; Ketelhuth DF J Intern Med; 2017 Apr; 281(4):383-397. PubMed ID: 28194913 [TBL] [Abstract][Full Text] [Related]
27. Impaired macrophage trafficking and increased helper T-cell recruitment with loss of cadherin-11 in atherosclerotic immune response. Johnson CL; Riley L; Bersi M; Linton MF; Merryman WD Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H756-H769. PubMed ID: 34506228 [TBL] [Abstract][Full Text] [Related]
28. Identification of Major Histocompatibility Complex Class II Epitopes From Lyme Autoantigen Apolipoprotein B-100 and Borrelia burgdorferi Mcp4 in Murine Lyme Arthritis. Danner R; Prochniak LM; Pereckas M; Rouse JR; Wahhab A; Hackner LG; Lochhead RB J Infect Dis; 2024 Aug; 230(Supplement_1):S27-S39. PubMed ID: 39140726 [TBL] [Abstract][Full Text] [Related]
29. B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells. Douna H; Amersfoort J; Schaftenaar FH; Kröner MJ; Kiss MG; Slütter B; Depuydt MAC; Bernabé Kleijn MNA; Wezel A; Smeets HJ; Yagita H; Binder CJ; Bot I; van Puijvelde GHM; Kuiper J; Foks AC Cardiovasc Res; 2020 Feb; 116(2):295-305. PubMed ID: 31150053 [TBL] [Abstract][Full Text] [Related]
30. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice. Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775 [TBL] [Abstract][Full Text] [Related]
31. Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity. Stern BV; Boehm BO; Tary-Lehmann M J Immunol; 2002 Jun; 168(12):6099-105. PubMed ID: 12055220 [TBL] [Abstract][Full Text] [Related]
32. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta. Butcher MJ; Waseem TC; Galkina EV Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405 [TBL] [Abstract][Full Text] [Related]
33. New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis. Tian S; Nakamura J; Hiller S; Simington S; Holley DW; Mota R; Willis MS; Bultman SJ; Luft JC; DeSimone JM; Jia Z; Maeda N; Yi X Vascul Pharmacol; 2020; 133-134():106777. PubMed ID: 32750408 [TBL] [Abstract][Full Text] [Related]
34. The alternation of autophagy/apoptosis in CD4+CD25+Foxp3+ Tregs on the developmental stages of atherosclerosis. Tian Y; Liang X; Wu Y Biomed Pharmacother; 2018 Jan; 97():1053-1060. PubMed ID: 29136784 [TBL] [Abstract][Full Text] [Related]
36. Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers. Bischof F; Hofmann M; Schumacher TN; Vyth-Dreese FA; Weissert R; Schild H; Kruisbeek AM; Melms A J Immunol; 2004 Mar; 172(5):2878-84. PubMed ID: 14978089 [TBL] [Abstract][Full Text] [Related]
37. IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis. Engelbertsen D; Rattik S; Wigren M; Vallejo J; Marinkovic G; Schiopu A; Björkbacka H; Nilsson J; Bengtsson E Cardiovasc Res; 2018 Jan; 114(1):180-187. PubMed ID: 29036304 [TBL] [Abstract][Full Text] [Related]
38. Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease. Saigusa R; Roy P; Freuchet A; Gulati R; Ghosheh Y; Suthahar SSA; Durant CP; Hanna DB; Kiosses WB; Orecchioni M; Wen L; Wu R; Kuniholm MH; Landay AL; Anastos K; Tien PC; Gange SJ; Kassaye S; Vallejo J; Hedrick CC; Kwok WW; Sette A; Hodis HN; Kaplan RC; Ley K Nat Cardiovasc Res; 2022 May; 1(5):462-475. PubMed ID: 35990517 [TBL] [Abstract][Full Text] [Related]
39. Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression. Bonacina F; Martini E; Svecla M; Nour J; Cremonesi M; Beretta G; Moregola A; Pellegatta F; Zampoleri V; Catapano AL; Kallikourdis M; Norata GD Cardiovasc Res; 2021 Jul; 117(9):2069-2082. PubMed ID: 32931583 [TBL] [Abstract][Full Text] [Related]
40. CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response. Kasahara K; Sasaki N; Yamashita T; Kita T; Yodoi K; Sasaki Y; Takeda M; Hirata K J Am Heart Assoc; 2014 Apr; 3(2):e000719. PubMed ID: 24755152 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]